EP0084102A1 - Plaque de micro-titrage pour diagnostique du groupe sanguin - Google Patents

Plaque de micro-titrage pour diagnostique du groupe sanguin Download PDF

Info

Publication number
EP0084102A1
EP0084102A1 EP82111063A EP82111063A EP0084102A1 EP 0084102 A1 EP0084102 A1 EP 0084102A1 EP 82111063 A EP82111063 A EP 82111063A EP 82111063 A EP82111063 A EP 82111063A EP 0084102 A1 EP0084102 A1 EP 0084102A1
Authority
EP
European Patent Office
Prior art keywords
wells
antisera
blood group
plate according
plate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP82111063A
Other languages
German (de)
English (en)
Other versions
EP0084102B1 (fr
Inventor
Horst Dr. Dipl.-Chem. Uthemann
Hans Dr. Dipl.-Chem. Schleussner
Dieter Dr. Dipl.-Chem. Merz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest AG
Original Assignee
Biotest Serum Institut GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut GmbH filed Critical Biotest Serum Institut GmbH
Priority to AT82111063T priority Critical patent/ATE16320T1/de
Publication of EP0084102A1 publication Critical patent/EP0084102A1/fr
Application granted granted Critical
Publication of EP0084102B1 publication Critical patent/EP0084102B1/fr
Expired legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S422/00Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing
    • Y10S422/906Plasma or ion generation means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S422/00Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing
    • Y10S422/907Corona or glow discharge means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809Multifield plates or multicontainer arrays

Definitions

  • the invention relates to a microtiter plate for blood group diagnostics.
  • the application includes determinations in the ABO, Rh and other systems and if necessary includes the antihuman globulin test. The execution of serum cross-tests is also described.
  • microtiter plates represent an improvement on the conventional methods, they all have in common that liquid antisera are either poured into the wells provided for this purpose immediately prior to the examination or are poured in and frozen in stock.
  • the object of the invention was therefore to provide a microtiter plate with which blood group determinations can be simplified considerably and can be automated to a certain extent.
  • a microtiter plate for blood group diagnosis consisting of a flat-bottom plate (1) made of a transparent, rigid plastic, which is equipped with a large number of cells (2), which is characterized in that the cell bases (3) have firmly adhering dry layers (4) consist of essentially pure antisera and the wells consist of a protein-binding plastic.
  • antisera adhere perfectly to rigid, transparent, protein-binding plastic without any adhesion-promoting additives.
  • Antisera which are introduced into the wells form a firmly adhering layer on the bottoms of the wells. Simulated transport conditions could not cause the layer to peel off.
  • ready-to-use microtiter plates coated with dried antiserum are thus provided, in which the use and filling in of liquid antisera is dispensed with.
  • Rehydration is unnecessary before use. Only a drop of saline suspension is added to the blood to be examined, and the antisera dissolve by shaking gently. After a short centrifugation (e.g. 2 minutes at 1000 rpm) - without previous incubation - the mixture is shaken and evaluated.
  • this plate has a large number of lengthways and crossways in wells arranged next to each other on one level. This offers a variety of options
  • the plates or well bases according to the invention are coated at least with antisera for blood group determination in the ABO and Rh systems.
  • the antisera for the ABO system are characterized by high avidity, while chemically modified antisera (e.g. Anti-D or Anti-CDE) are used for the Rh system, which also agglutinate quickly in the saline environment.
  • Chemically modified IgG molecules in which disulfide bridges in the hinge region have been partially reductively split and alkylated, are characterized by a high degree of flexibility, which is why antisera based on the modified molecules are based on the usual addition of supplements (e.g. albumin, Dextran, gelatin, AB serum, etc.) can be dispensed with.
  • supplements e.g. albumin, Dextran, gelatin, AB serum, etc.
  • the chemical modification converts incomplete antibodies into agglutinins that have similar properties to ABO test sera.
  • anti-D D (Rh o ) -positive erythrocytes in saline solution or in compatible serum or plasma are agglutinated with modified IgG of specificity.
  • Pirofsky B In Pirofsky B.
  • the anti-D reagent dried on the plastic cup wells and without having to be dissolved with water beforehand, after stirring with D (Rh o ) positive blood after a short reaction time (approx. 1 minute) provides agglutination images comparable in strength to the ABO system. Since neither the reagent itself contains any supplements, nor does it require highly polymeric, adhesion-promoting additives to dry on the well bottom, there is no need for a control.
  • the anti-D reagent with its low protein concentration which corresponds to the concentration of normal human serum, leads to false positive reactions with IgG and / or complement-loaded erythrocytes in autoimmune diseases or Erythroblastosis of the newborn leads, which however are frequently observed with incomplete anti-Rh sera, which contain bovine albumin or other high-molecular substances as enhancement medium.
  • the plates can expediently also be coated with Anti-AB, AB-Serum, Anti-Kell and other systems.
  • the plate should therefore have a sufficient number of cells in order to be able to carry out coatings with all desired systems. At least 7 to 8 wells should be arranged transversely next to each other. Commercially available plates have 96 cells, i.e. 8 rows of cells arranged side by side in the transverse direction and 12 side by side in the longitudinal direction.
  • the antisera layers can be colored differently.
  • the ready-to-use sheets are individually sealed in aluminum bags and stored at 2 to 8 ° C.
  • Fig. 1 shows a plan view of a flat-bottom plate (1) with a plurality of cylindrical cups (2) attached to one another, the bases of which are provided with an antiserum layer (4).
  • a frame (5) extends around the entire well arrangement, which is provided with a shoulder (6) on which a lid can be placed.
  • the longitudinal rows of cells are designated with A, B, C, etc. and the transverse rows of cells with 1, 2, 3, etc.
  • Fig. 2 shows a section AA through Fig. 1, wherein the cylindrical cups (2) with bottoms (3) and antiserum layer (4) can be seen, which are surrounded by frame (5) with paragraph (6) on the the lid (7) can be put on.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP82111063A 1981-12-28 1982-11-30 Plaque de micro-titrage pour diagnostique du groupe sanguin Expired EP0084102B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT82111063T ATE16320T1 (de) 1981-12-28 1982-11-30 Mikrotiterplatte zur blutgruppendiagnostik.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19818137962U DE8137962U1 (de) 1981-12-28 1981-12-28 Mikrotiterplatte zur blutgruppendiagnostik
DE8137962U 1981-12-28

Publications (2)

Publication Number Publication Date
EP0084102A1 true EP0084102A1 (fr) 1983-07-27
EP0084102B1 EP0084102B1 (fr) 1985-10-30

Family

ID=6734273

Family Applications (1)

Application Number Title Priority Date Filing Date
EP82111063A Expired EP0084102B1 (fr) 1981-12-28 1982-11-30 Plaque de micro-titrage pour diagnostique du groupe sanguin

Country Status (4)

Country Link
US (1) US4770856A (fr)
EP (1) EP0084102B1 (fr)
AT (1) ATE16320T1 (fr)
DE (2) DE8137962U1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177352A1 (fr) * 1984-10-04 1986-04-09 The State Of Victoria Immuno-essai enzymatique (ELISA)
DE3619107A1 (de) * 1985-07-01 1987-01-08 Jenoptik Jena Gmbh Probenkoerper zur diskreten analyse fluessiger analysenansaetze
EP0331808A1 (fr) * 1988-01-28 1989-09-13 Biotest AG Méthode d'essai immunologique pour déterminer des groupes sanguins
EP0363510A1 (fr) * 1988-10-12 1990-04-18 Biotest AG Procédés de recherche et d'identification des anticorps d'érythrocyte à l'aide d'une méthode à phase solide
DE9015317U1 (fr) * 1990-11-07 1991-03-14 Panitz, Norbert, Dr., 6500 Mainz, De
EP0522134A1 (fr) * 1991-01-11 1993-01-13 COBE Laboratories, Inc. Procede de detection de types anticorpaux en circulation a l'aide de cellules ou matieres cellulaires sechees ou lyophilisees
US5213963A (en) * 1988-10-12 1993-05-25 Biotest Aktiengesellschaft Procedure for finding and identifying red cell antibodies by means of the solid phase method
FR2694809A1 (fr) * 1992-08-11 1994-02-18 Mikralgen Dispositif réactionnel pour identifier un produit, et son procédé d'obtention.
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323645A1 (de) * 1983-07-01 1985-01-10 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Diagnostisches testsystem
HU192513B (en) * 1984-11-23 1987-06-29 Human Oltoanyagtermelo Quick diagnostic substance for determining blood group
US4977078A (en) * 1987-12-22 1990-12-11 Olympus Optical Co., Ltd. Plate substrate immunoassay device and method for performing a multi-test immunoassay on a specimen
US5229163A (en) * 1989-12-21 1993-07-20 Hoffmann-La Roche Inc. Process for preparing a microtiter tray for immunometric determinations
US5041266A (en) * 1989-12-21 1991-08-20 Hoffmann-La Roche Inc. Tray for immunometric determinations
US5188965A (en) * 1991-03-18 1993-02-23 Difco Laboratories Reagent source for chemiluminescent reactions, test kit, and method for use
US5443743A (en) * 1991-09-11 1995-08-22 Pall Corporation Gas plasma treated porous medium and method of separation using same
US5221410A (en) * 1991-10-09 1993-06-22 Schering Corporation Crystal forming device
US5211182A (en) * 1991-10-23 1993-05-18 Deutsch Marshall E Home ovulation test kit and method
DE4209064C2 (de) * 1992-03-20 1995-07-27 Gerhard Dr Noss Verfahren zum Zuführen von Waschflüssigkeit zu kleinen, transparenten, mit Zellkulturen beschichteten Testfeldern und zum Absaugen der Waschflüssigkeit von den Testfeldern
US5319436A (en) * 1992-05-28 1994-06-07 Packard Instrument Company, Inc. Microplate farming wells with transparent bottom walls for assays using light measurements
FR2700010B1 (fr) * 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
DE4416640A1 (de) * 1994-05-11 1995-11-16 A I D Autoimmun Diagnostika Gm Objektträger für die mikroskopische Diagnose aus Kunststoffmaterial, Herstellungsverfahren und Verwendung
US5935847A (en) 1994-10-28 1999-08-10 Baxter International Inc. Multilayer gas-permeable container for the culture of adherent and non-adherent cells
US6297046B1 (en) 1994-10-28 2001-10-02 Baxter International Inc. Multilayer gas-permeable container for the culture of adherent and non-adherent cells
US5922534A (en) * 1995-03-28 1999-07-13 Hewlett-Packard Company Dry biochemical assay plate and method for making the same
IL113920A (en) * 1995-05-30 1999-09-22 Avraham Reinhartz Apparatus and method for detection of analytes in a sample
US6024220A (en) 1995-06-07 2000-02-15 Baxter International Inc. Encapsulated seam for multilayer materials
US6391404B1 (en) 1995-06-07 2002-05-21 Baxter International Inc. Coextruded multilayer film materials and containers made therefrom
US5766554A (en) * 1996-07-19 1998-06-16 Liu; Rui Ye Immunoassay plates with desiccant housing
US6063338A (en) 1997-06-02 2000-05-16 Aurora Biosciences Corporation Low background multi-well plates and platforms for spectroscopic measurements
US5910287A (en) * 1997-06-03 1999-06-08 Aurora Biosciences Corporation Low background multi-well plates with greater than 864 wells for fluorescence measurements of biological and biochemical samples
US6171780B1 (en) 1997-06-02 2001-01-09 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US6426050B1 (en) 1997-05-16 2002-07-30 Aurora Biosciences Corporation Multi-well platforms, caddies, lids and combinations thereof
US6229603B1 (en) 1997-06-02 2001-05-08 Aurora Biosciences Corporation Low background multi-well plates with greater than 864 wells for spectroscopic measurements
US6517781B1 (en) 1997-06-02 2003-02-11 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
US6096562A (en) * 1997-10-27 2000-08-01 Nalge Nunc International Corporation Multi-slide assembly including slide, frame and strip cap, and methods thereof
US6861035B2 (en) 1998-02-24 2005-03-01 Aurora Discovery, Inc. Multi-well platforms, caddies, lids and combinations thereof
US6825042B1 (en) 1998-02-24 2004-11-30 Vertex Pharmaceuticals (San Diego) Llc Microplate lid
US6027695A (en) * 1998-04-01 2000-02-22 Dupont Pharmaceuticals Company Apparatus for holding small volumes of liquids
DE29811606U1 (de) * 1998-06-29 1999-05-06 Sension Biolog Detektions Und Kombi-Vorrichtung zur simultanen Durchführung von Immunfiltrationstests
US6399394B1 (en) 1999-06-30 2002-06-04 Agilent Technologies, Inc. Testing multiple fluid samples with multiple biopolymer arrays
US6635430B1 (en) * 1999-07-16 2003-10-21 Dupont Pharmaceuticals Company Filtrate plate device and reversible-well plate device
US6555392B1 (en) * 1999-09-13 2003-04-29 Helena Laboratories Corporation Antisera tray
US7005029B2 (en) * 1999-10-26 2006-02-28 Nalge Nunc International Corporation Method of making a multi-well test plate having adhesively secured transparent bottom panel
US6455007B1 (en) * 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium
US20040018615A1 (en) * 2000-08-02 2004-01-29 Garyantes Tina K. Virtual wells for use in high throughput screening assays
US6800491B2 (en) 2001-06-08 2004-10-05 Nalge Nunc International Corporation Robotic reservoir without liquid hangup
PL367715A1 (en) * 2001-09-20 2005-03-07 3-Dimensional Pharmaceuticals, Inc. Conductive microtiter plate
US7354597B2 (en) * 2001-12-03 2008-04-08 Massachusetts Institute Of Technology Microscale lyophilization and drying methods for the stabilization of molecules
US7332029B2 (en) * 2002-01-18 2008-02-19 Neuro Probe Incorporated Crystal forming apparatus and method for using same
JP2005515151A (ja) * 2002-01-18 2005-05-26 ニューロ プローブ インコーポレイテッド 結晶形成装置およびその使用方法
KR100719029B1 (ko) * 2002-03-28 2007-05-16 대한제당 주식회사 마이크로-웰 플레이트
US7537936B2 (en) * 2002-05-31 2009-05-26 Agilent Technologies, Inc. Method of testing multiple fluid samples with multiple biopolymer arrays
JP2004045104A (ja) * 2002-07-09 2004-02-12 Futaba Corp マイクロプレート
US20050112033A1 (en) * 2003-09-08 2005-05-26 Irm, Llc Multi-well containers, systems, and methods of using the same
NL1024578C2 (nl) * 2003-10-21 2005-04-22 Univ Delft Tech Inrichting voor het uitvoeren van een reactie.
US20050173059A1 (en) * 2004-02-11 2005-08-11 Nalge Nunc International Corporation Methods of making a multi-well test plate having an adhesively secured transparent bottom panel
US7384779B2 (en) * 2004-04-12 2008-06-10 Corning Incorporated Porous substrate plates and the use thereof
GB0506183D0 (en) * 2005-03-24 2005-05-04 Univ Edinburgh Antigen detection
JP5080494B2 (ja) 2005-12-21 2012-11-21 メソ スケール テクノロジーズ エルエルシー アッセイ装置、方法および試薬
KR101489804B1 (ko) * 2005-12-21 2015-02-05 메소 스케일 테크놀러지즈, 엘엘시 분석 시약을 갖는 분석 모듈 및 그것의 제조 및 사용 방법
US20080280310A1 (en) * 2007-05-09 2008-11-13 Louis Panagopoulos Testing for Blood Group Immunological Reaction Without the Use of Anti-Human Globulin
CA2691451C (fr) 2007-06-21 2015-03-24 Sara H. Fan Instruments et receptacles pour effectuer des procedes
US9594019B1 (en) * 2013-08-09 2017-03-14 Lester F. Ludwig Optical tomography for microscopy, cell cytometry, microplate array instrumentation, crystallography, and other applications
US20170189902A1 (en) * 2014-09-12 2017-07-06 Pinpoint Testing, Llc Ready-to-constitute analytical platforms for chemical analyses and quantification
WO2016117541A1 (fr) * 2015-01-22 2016-07-28 株式会社村田製作所 Structure de réseau de vide et son procédé de production
WO2016172362A1 (fr) * 2015-04-21 2016-10-27 General Automation Lab Technologies, Inc. Systèmes à haute résolution, trousses, appareil, et procédés pour applications de microbiologie à rendement élevé
EP3511700B1 (fr) * 2016-09-06 2023-10-04 Keio University Procédé de mesure de l'effet protecteur uv ou infrarouge d'une composition aqueuse et dispositif de préparation d'un échantillon de mesure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2152068A1 (de) * 1970-10-19 1972-04-20 Astec Inc Vorrichtung zur Untersuchung der biologischen Wirksamkeit von Kontrollreagenzien
DE2636616A1 (de) * 1975-08-14 1977-02-24 Sinai School Medicine Monolayer von irreversibel auf einem festen traeger gebundenen zellen, verfahren zu seiner herstellung und seine verwendung zur durchfuehrung immunologischer reaktionen
DE2938009A1 (de) * 1979-09-20 1981-04-30 Ernst Dr. 5300 Bonn Cohnen Serco-spezial-tuepfelplatte zur blutgruppenbestimmung
DE8029596U1 (de) * 1980-11-06 1981-06-11 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Blutgruppenidentitaetskarte, insbesondere fuer den bed side-test

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
GB1447493A (en) * 1973-02-01 1976-08-25 Ici Ltd Coated synthetic film materials electric circuit arrangements for energising electromagnetic
FR2296869A1 (fr) * 1975-01-06 1976-07-30 Al Marachy Pierre Installation pour la determination du groupe sanguin
US4154795A (en) * 1976-07-23 1979-05-15 Dynatech Holdings Limited Microtest plates
US4284725A (en) * 1976-08-13 1981-08-18 Dynasciences Corporation Virus titration and identification system
US4337104A (en) * 1978-10-10 1982-06-29 Becton, Dickinson And Company Method for manufacturing a roller bottle
US4613317A (en) * 1983-11-07 1986-09-23 Nissan Motor Co., Ltd. Cardan universal joints

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2152068A1 (de) * 1970-10-19 1972-04-20 Astec Inc Vorrichtung zur Untersuchung der biologischen Wirksamkeit von Kontrollreagenzien
DE2636616A1 (de) * 1975-08-14 1977-02-24 Sinai School Medicine Monolayer von irreversibel auf einem festen traeger gebundenen zellen, verfahren zu seiner herstellung und seine verwendung zur durchfuehrung immunologischer reaktionen
DE2938009A1 (de) * 1979-09-20 1981-04-30 Ernst Dr. 5300 Bonn Cohnen Serco-spezial-tuepfelplatte zur blutgruppenbestimmung
DE8029596U1 (de) * 1980-11-06 1981-06-11 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Blutgruppenidentitaetskarte, insbesondere fuer den bed side-test

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177352A1 (fr) * 1984-10-04 1986-04-09 The State Of Victoria Immuno-essai enzymatique (ELISA)
DE3619107A1 (de) * 1985-07-01 1987-01-08 Jenoptik Jena Gmbh Probenkoerper zur diskreten analyse fluessiger analysenansaetze
EP0331808A1 (fr) * 1988-01-28 1989-09-13 Biotest AG Méthode d'essai immunologique pour déterminer des groupes sanguins
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
EP0363510A1 (fr) * 1988-10-12 1990-04-18 Biotest AG Procédés de recherche et d'identification des anticorps d'érythrocyte à l'aide d'une méthode à phase solide
US5213963A (en) * 1988-10-12 1993-05-25 Biotest Aktiengesellschaft Procedure for finding and identifying red cell antibodies by means of the solid phase method
DE9015317U1 (fr) * 1990-11-07 1991-03-14 Panitz, Norbert, Dr., 6500 Mainz, De
EP0522134A1 (fr) * 1991-01-11 1993-01-13 COBE Laboratories, Inc. Procede de detection de types anticorpaux en circulation a l'aide de cellules ou matieres cellulaires sechees ou lyophilisees
EP0522134A4 (fr) * 1991-01-11 1994-01-26 Cryopharm Corporation
FR2694809A1 (fr) * 1992-08-11 1994-02-18 Mikralgen Dispositif réactionnel pour identifier un produit, et son procédé d'obtention.

Also Published As

Publication number Publication date
US4770856A (en) 1988-09-13
EP0084102B1 (fr) 1985-10-30
DE3267183D1 (en) 1985-12-05
ATE16320T1 (de) 1985-11-15
DE8137962U1 (de) 1982-06-16

Similar Documents

Publication Publication Date Title
EP0084102B1 (fr) Plaque de micro-titrage pour diagnostique du groupe sanguin
EP0305337B1 (fr) Procédé de détection des antigènes et/ou des anticorps et nécéssaire pour sa mise en oeuvre
EP1711820B1 (fr) Procede et dispositif pour deceler la presence d'analytes par visualisation et separation de matieres agglutinees
US4472357A (en) Blood bank cuvette cassette and label therefor
DE69732662T2 (de) Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen
EP0163799B1 (fr) Support enduit d'antigènes ou d'anticorps
DE2905558A1 (de) Verfahren und vorrichtung fuer automatisiertes messen der ergebnisse von agglutinationsversuchen z.b. im spektrophotometer, adsorptionsphotometer, fluorometer oder nephelometer
DE2930706A1 (de) Verfahren zum nachweis von erregerspezifischen antikoerpern
EP0058780B1 (fr) Procédé de détermination d'antigènes ou d'anticorps
van Rood Microlymphocytotoxicity method
DE2907198C2 (fr)
DE60119079T2 (de) System und verfahren für immunologische assays
DE602004012161T2 (de) Verkürzung der zeit bis zum vorliegen von blutbankdiagnostikergebnissen
EP0051748B1 (fr) Carte pour l'identification du groupe sanguin, particulièrement pour le "bed side test"
EP0130434B1 (fr) Système de test diagnostique
DE4222573C1 (fr)
EP0331808B1 (fr) Méthode d'essai immunologique pour déterminer des groupes sanguins
WO1987003965A1 (fr) Bandelettes multi-indicatrices pour analyse immunologique, leur utilisation et leur fabrication
Ottenberg et al. STUDIES IN ISOAGGLUTINATION: II. THE OCCURRENCE OF GROUPED ISOAGGLUTINATION IN THE LOWER ANIMALS.
DE102014007851B3 (de) Vorrichtung und Verfahren zur Bestimmung von Blutgruppenantigenen mit einem inkompletten Antikörper
EP0487459B1 (fr) Procédé pour la détection d'anticorps
DE2636616C2 (fr)
WO2004019038A2 (fr) Procede pour identifier des anticorps et/ou des antigenes dans un liquide a tester, notamment lors d'une determination de groupe sanguin
US20230062669A1 (en) Method for capturing and identifying cellular agglutinates for detecting multiplex anti-erythrocyte antibodies
DD225795A1 (de) Festphasen-immunoassay an cellulosehaltigen materialien

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19831124

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 16320

Country of ref document: AT

Date of ref document: 19851115

Kind code of ref document: T

ET Fr: translation filed
REF Corresponds to:

Ref document number: 3267183

Country of ref document: DE

Date of ref document: 19851205

BECN Be: change of holder's name

Effective date: 19851030

ITF It: translation for a ep patent filed

Owner name: ING. A. GIAMBROCONO & C. S.R.L.

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Free format text: BIOTEST AKTIENGESELLSCHAFT

REG Reference to a national code

Ref country code: FR

Ref legal event code: CN

NLS Nl: assignments of ep-patents

Owner name: BIOTEST AKTIENGESELLSCHAFT TE FRANKFORT A.D. MAIN,

BECN Be: change of holder's name

Effective date: 19880114

ITTA It: last paid annual fee
EPTA Lu: last paid annual fee
EAL Se: european patent in force in sweden

Ref document number: 82111063.2

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20011106

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20011113

Year of fee payment: 20

Ref country code: AT

Payment date: 20011113

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20011123

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20011128

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20011129

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20011214

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20011217

Year of fee payment: 20

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20020128

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021129

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021129

Ref country code: CH

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021129

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021130

Ref country code: LU

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021130

Ref country code: AT

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20021130

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Effective date: 20021129

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV7 Nl: ceased due to reaching the maximum lifetime of a patent

Effective date: 20021130

EUG Se: european patent has lapsed